Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    10904452 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Evaluation of the Initial Prescription of Ketamine and Milnacipran for Depression in Palliative Care
Condition: Depression
Interventions: Drug: Ketamine;   Drug: Milnacipran;   Drug: Placebo
2 Completed Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
Condition: Myocardial Infarction
Interventions: Drug: FDC;   Drug: Separately drugs, simvastatin, aspirin and ramipril

Indicates status has not been verified in more than two years